📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Creative Eye Board Approves Delayed Financial Results for Sept 2025 and Dec 2024
Creative Eye Limited held a board meeting on February 17, 2026, to approve financial results for multiple past periods. The board cleared the standalone un-audited results for the quarter and half-year ended September 30, 2025, along with the statement of assets and liabilities. Notably, the board also approved results for the quarter and nine months ended December 31, 2024, which appear to be significantly delayed. Statutory auditors have issued limited review reports for all the aforementioned periods.
Key Highlights
Approval of Standalone Un-audited Financial Results for the quarter and half-year ended September 30, 2025.
Approval of Standalone Un-audited Financial Results for the quarter and nine months ended December 31, 2024.
Statutory Auditors issued Limited Review Reports for both the 2024 and 2025 reporting periods.
The board meeting concluded after approximately 3 hours and 20 minutes of deliberation.
The delayed approval of 2024 results alongside 2025 results suggests a regulatory catch-up by the company.
💼 Action for Investors
Investors should carefully examine the specific financial data once the full results are uploaded to understand the company's fiscal health and the reasons behind the reporting delays. The backlog in financial reporting is a point of concern that requires further investigation into the company's internal controls.
Creative Eye Approves Delayed Financial Results for Sept 2025 and Dec 2024
Creative Eye Limited's board met on February 17, 2026, to approve overdue financial statements. The board cleared standalone unaudited results for the quarter and half-year ended September 30, 2025, along with the cash flow statement. Furthermore, the results for the quarter and nine months ended December 31, 2024, were also approved. This catch-up in reporting suggests the company is addressing significant compliance backlogs.
Key Highlights
Approved standalone unaudited financial results for the quarter and half-year ended September 30, 2025.
Approved standalone unaudited financial results for the quarter and nine months ended December 31, 2024.
Limited Review Reports from Statutory Auditors were received for both reporting periods.
The board meeting lasted approximately three hours and twenty minutes to conclude these approvals.
💼 Action for Investors
Investors should carefully review the detailed financial statements for any auditor qualifications and the reasons behind the significant reporting delays. Exercise caution as delayed filings can be a sign of internal control weaknesses.
Creative Eye Approves Financial Results for Sept 2025 and Dec 2024 Quarters
Creative Eye Limited's board met on February 17, 2026, to approve financial results for multiple past periods, indicating a catch-up on regulatory filings. The board approved standalone unaudited results for the quarter and half-year ended September 30, 2025. Simultaneously, results for the quarter and nine months ended December 31, 2024, were also cleared. This suggests a significant delay in the company's standard reporting timeline which is now being addressed through these approvals.
Key Highlights
Approved standalone unaudited financial results for the quarter and half-year ended September 30, 2025.
Approved standalone unaudited financial results for the quarter and nine months ended December 31, 2024.
Statutory Auditors issued Limited Review Reports for both the 2024 and 2025 reporting periods.
The board meeting was conducted at the Mumbai registered office and concluded at 3:20 P.M.
💼 Action for Investors
Investors should carefully examine the detailed financial statements for both periods to identify any underlying operational issues that caused the reporting delays. Exercise caution until the company demonstrates a return to a regular, timely reporting schedule.
Creative Eye Appoints Ashutosh Kochhar as MD and Sachin Devare as CFO
Creative Eye Limited has announced a major leadership transition following its Extraordinary General Meeting on February 13, 2026. Mr. Ashutosh Kochhar has been appointed as Managing Director for a five-year term, while Mr. Sachin Devare, a Chartered Accountant with over 18 years of experience, has been named Chief Financial Officer. The company also filled a casual vacancy in its statutory auditor position by appointing M/s. STDJ & Co. following the resignation of the previous auditors. These changes represent a significant refresh of the company's top management and financial oversight functions.
Key Highlights
Mr. Ashutosh Kochhar appointed as Managing Director and KMP for a 5-year term effective February 13, 2026
Mr. Sachin Devare appointed as Chief Financial Officer bringing over 18 years of experience in financial controllership
M/s. STDJ & Co., Chartered Accountants, appointed as Statutory Auditors to fill the vacancy caused by the resignation of M/s. NGS & Co. LLP
M/s. Kirty Vaidya & Associates appointed as Secretarial Auditors for the company
💼 Action for Investors
Investors should monitor the strategic direction under the new Managing Director and observe the impact of the new CFO on the company's financial reporting and cost management. The change in statutory auditors also warrants a review of the next set of audited financial results for any adjustments.
Creative Eye Appoints 3 New Independent Directors and Reconstitutes Board Committees
Creative Eye Limited has announced a significant reshuffle of its Board of Directors following a meeting on December 8, 2025. The company accepted the resignation of Ms. Sarita Soni and appointed three new Independent Directors—Dr. Madan Bhalchandra Gosavi, Mr. Charuhas Patil, and Mr. Amit Doshi—for a three-year term. Notably, Dr. Gosavi, a former District Judge and NCLT member, will now chair the Audit and Nomination & Remuneration Committees. The board also adjourned discussions on certain undisclosed agenda items, citing the need for further information.
Key Highlights
Appointment of 3 new Independent Directors for a 3-year term effective December 8, 2025.
Resignation of Ms. Sarita Soni as Independent Director due to pre-occupation.
Dr. Madan Bhalchandra Gosavi, a former NCLT Judicial Member, appointed as Chairman of Audit and NRC Committees.
Full reconstitution of Audit, Nomination & Remuneration, and Stakeholders Relationship Committees.
Adjournment of specific agenda items to a future meeting date pending further clarifications.
💼 Action for Investors
Investors should monitor the company for the announcement of the adjourned meeting date, as pending agenda items may contain strategic updates. The addition of a former NCLT member suggests a focus on strengthening legal and corporate governance.